Zee-Fen Chang

2.2k total citations
59 papers, 1.7k citations indexed

About

Zee-Fen Chang is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Zee-Fen Chang has authored 59 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 18 papers in Oncology and 13 papers in Cell Biology. Recurrent topics in Zee-Fen Chang's work include Cancer-related Molecular Pathways (15 papers), Microtubule and mitosis dynamics (10 papers) and DNA Repair Mechanisms (9 papers). Zee-Fen Chang is often cited by papers focused on Cancer-related Molecular Pathways (15 papers), Microtubule and mitosis dynamics (10 papers) and DNA Repair Mechanisms (9 papers). Zee-Fen Chang collaborates with scholars based in Taiwan, United States and Germany. Zee-Fen Chang's co-authors include Po‐Yuan Ke, Gary Bokoch, Perihan Nalbant, Jörg Birkenfeld, Duen-Yi Huang, Liu C, Yuan‐Yeh Kuo, Kuang Yu Chen, Chunmei Hu and Jinmei Lai and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Zee-Fen Chang

58 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zee-Fen Chang Taiwan 23 1.0k 429 354 184 170 59 1.7k
Evan Ingley Australia 25 1.5k 1.4× 339 0.8× 368 1.0× 216 1.2× 159 0.9× 66 2.3k
Angus J.M. Cameron United Kingdom 23 1.3k 1.3× 346 0.8× 310 0.9× 76 0.4× 165 1.0× 40 2.0k
Nicole M. Verrills Australia 28 1.8k 1.7× 456 1.1× 413 1.2× 141 0.8× 357 2.1× 69 2.7k
Kathrin H. Kirsch United States 24 1.5k 1.5× 326 0.8× 364 1.0× 173 0.9× 356 2.1× 44 2.2k
Matthieu Lacroix France 18 1.1k 1.1× 245 0.6× 516 1.5× 104 0.6× 302 1.8× 28 2.0k
Rina Plattner United States 24 1.1k 1.1× 260 0.6× 452 1.3× 182 1.0× 170 1.0× 39 1.9k
Roberta Bortul Italy 26 1.7k 1.6× 220 0.5× 349 1.0× 134 0.7× 219 1.3× 60 2.2k
Andrew Pierce United Kingdom 23 1.3k 1.2× 170 0.4× 423 1.2× 287 1.6× 270 1.6× 69 2.2k
Hisakazu Fujita Japan 22 1.1k 1.1× 576 1.3× 389 1.1× 46 0.3× 239 1.4× 67 1.9k
I. Hiles United Kingdom 12 2.1k 2.0× 585 1.4× 482 1.4× 184 1.0× 104 0.6× 12 2.6k

Countries citing papers authored by Zee-Fen Chang

Since Specialization
Citations

This map shows the geographic impact of Zee-Fen Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zee-Fen Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zee-Fen Chang more than expected).

Fields of papers citing papers by Zee-Fen Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zee-Fen Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zee-Fen Chang. The network helps show where Zee-Fen Chang may publish in the future.

Co-authorship network of co-authors of Zee-Fen Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Zee-Fen Chang. A scholar is included among the top collaborators of Zee-Fen Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zee-Fen Chang. Zee-Fen Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Shengyang, et al.. (2024). Glutathione determines chronic myeloid leukemia vulnerability to an inhibitor of CMPK and TMPK. Communications Biology. 7(1). 843–843. 5 indexed citations
2.
Chen, Chih‐Wei, Tung Chao, Kai‐Chien Yang, et al.. (2024). NME3 is a gatekeeper for DRP1-dependent mitophagy in hypoxia. Nature Communications. 15(1). 2264–2264. 9 indexed citations
4.
Liao, Wei‐Ting, et al.. (2023). CBAP regulates the function of Akt-associated TSC protein complexes to modulate mTORC1 signaling. Journal of Biological Chemistry. 299(12). 105455–105455. 3 indexed citations
5.
Chang, Yu‐Chen, Chih‐Wei Chen, Reika Tei, et al.. (2023). NME3 binds to phosphatidic acid and mediates PLD6-induced mitochondrial tethering. The Journal of Cell Biology. 222(10). 15 indexed citations
6.
Chen, Wei‐Yi, et al.. (2022). DNMT3b protects centromere integrity by restricting R-loop-mediated DNA damage. Cell Death and Disease. 13(6). 546–546. 15 indexed citations
7.
Chen, Yee‐Chun, et al.. (2019). The Ca-loop in thymidylate kinase is critical for growth and contributes to pyrimidine drug sensitivity of Candida albicans. Journal of Biological Chemistry. 294(27). 10686–10697. 6 indexed citations
8.
Guo, Jianru, Christopher Wai Kei Lam, Cai-Yun Wang, et al.. (2016). Profiling ribonucleotide and deoxyribonucleotide pools perturbed by gemcitabine in human non-small cell lung cancer cells. Scientific Reports. 6(1). 37250–37250. 10 indexed citations
9.
Shen, Rong‐Fong, Ching‐Yi Liu, Yang‐Kao Wang, et al.. (2014). GEF-H1 controls focal adhesion signaling that regulates mesenchymal stem cell lineage commitment. Journal of Cell Science. 127(Pt 19). 4186–200. 30 indexed citations
10.
Chang, Po‐Yuan, Karen Chang, Kai Chen, et al.. (2009). Formulation of novel lipid-coated magnetic nanoparticles as the probe for in vivo imaging. Journal of Biomedical Science. 16(1). 86–86. 45 indexed citations
11.
Tien, Hwei‐Fang, et al.. (2009). p210Bcr−Abl desensitizes Cdc42 GTPase signaling for SDF-1α-directed migration in chronic myeloid leukemia cells. Oncogene. 28(46). 4105–4115. 14 indexed citations
12.
Nalbant, Perihan, et al.. (2008). GEF-H1 Couples Nocodazole-induced Microtubule Disassembly to Cell Contractility via RhoA. Molecular Biology of the Cell. 19(5). 2147–2153. 273 indexed citations
13.
Ke, Po‐Yuan, et al.. (2005). Control of dTTP pool size by anaphase promoting complex/cyclosome is essential for the maintenance of genetic stability. Genes & Development. 19(16). 1920–1933. 73 indexed citations
14.
Li, Chia‐Lung, et al.. (2003). Perturbation of ATP-induced tetramerization of human cytosolic thymidine kinase by substitution of serine-13 with aspartic acid at the mitotic phosphorylation site. Biochemical and Biophysical Research Communications. 313(3). 587–593. 20 indexed citations
15.
Chang, Zee-Fen, et al.. (2001). Cap-independent translation conferred by the 5′-untranslated region of human thymidine kinase mRNA. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1519(3). 209–215. 8 indexed citations
16.
Chang, Zee-Fen & Duen-Yi Huang. (2001). Regulation of Thymidine Kinase Expression during Cellular Senescence. Journal of Biomedical Science. 8(2). 176–183. 10 indexed citations
17.
Lai, Jinmei, et al.. (2001). Lysophosphatidic acid promotes phorbol-ester-induced apoptosis in TF-1 cells by interfering with adhesion. Biochemical Journal. 359(1). 227–227. 25 indexed citations
18.
Chang, Zee-Fen, et al.. (1995). Different Regulation of the Human Thymidine Kinase Promoter in Normal Human Diploid IMR-90 Fibroblasts and HeLa Cells. Journal of Biological Chemistry. 270(45). 27374–27379. 23 indexed citations
19.
Chang, Zee-Fen & Duen-Yi Huang. (1994). Decline of Protein Kinase C Activation in Response to Growth Stimulation during Senescence of IMR-90 Human Diploid Fibroblasts. Biochemical and Biophysical Research Communications. 200(1). 16–27. 13 indexed citations
20.
Chang, Zee-Fen. (1990). Post-transcriptional regulation of thymidine kinase gene expression during monocytic differentiation of HL60 promyelocytes. Biochemical and Biophysical Research Communications. 169(2). 780–787. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026